Summit Securities Group’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-76
Closed -$1.5K 1030
2025
Q1
$1.5K Buy
+76
New +$1.5K ﹤0.01% 549